vs
Farmmi, Inc.（FAMI）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
ROCKWELL MEDICAL, INC.的季度营收约是Farmmi, Inc.的1.1倍（$18.3M vs $16.1M），Farmmi, Inc.净利率更高（-0.3% vs -3.0%，领先2.7%），ROCKWELL MEDICAL, INC.同比增速更快（-25.6% vs -55.7%），Farmmi, Inc.自由现金流更多（$14.6M vs $2.2M）
Farmmi, Inc.是一家经营农产品加工与销售业务的跨国企业，核心业务包括香菇、木耳等多种食用真菌的培育与市场推广，产品品类涵盖竹荪、栗蘑、舞茸、猴头菇等多个品种。公司旗下运营Farmmi Jicai线上店铺，推出Forasen、Farmmi Liangpin品牌的食用菌产品，同时对外出口整朵干香菇与切片干香菇。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
FAMI vs RMTI — 直观对比
营收规模更大
RMTI
是对方的1.1倍
$16.1M
营收增速更快
RMTI
高出30.1%
-55.7%
净利率更高
FAMI
高出2.7%
-3.0%
自由现金流更多
FAMI
多$12.3M
$2.2M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.1M | $18.3M |
| 净利润 | $-44.0K | $-554.0K |
| 毛利率 | 5.0% | 21.1% |
| 营业利润率 | -4.1% | -2.2% |
| 净利率 | -0.3% | -3.0% |
| 营收同比 | -55.7% | -25.6% |
| 净利润同比 | -107.0% | 26.7% |
| 每股收益（稀释后） | $-0.04 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FAMIRMTI
| Q4 25 | — | $18.3M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | — | $16.1M | ||
| Q1 25 | $16.1M | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | $36.4M | $22.7M |
净利润FAMIRMTI
| Q4 25 | — | $-554.0K | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-44.0K | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $343.0K | ||
| Q1 24 | $630.5K | $-1.7M |
毛利率FAMIRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | 5.0% | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | 5.9% | 13.5% |
营业利润率FAMIRMTI
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | -4.1% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | 2.5% | -5.8% |
净利率FAMIRMTI
| Q4 25 | — | -3.0% | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | — | -9.3% | ||
| Q1 25 | -0.3% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 1.7% | -7.6% |
每股收益（稀释后）FAMIRMTI
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | $-0.04 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | $1.20 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $166.4M | $37.0M |
| 总资产 | $230.4M | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FAMIRMTI
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
股东权益FAMIRMTI
| Q4 25 | — | $37.0M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | — | $30.4M | ||
| Q1 25 | $166.4M | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | — | $23.5M | ||
| Q1 24 | $164.4M | $20.6M |
总资产FAMIRMTI
| Q4 25 | — | $57.1M | ||
| Q3 25 | — | $57.5M | ||
| Q2 25 | — | $52.6M | ||
| Q1 25 | $230.4M | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | — | $53.0M | ||
| Q1 24 | $171.9M | $50.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.6M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $14.6M | $2.2M |
| 自由现金流率自由现金流/营收 | 90.1% | 12.0% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.2M |
8季度趋势，按日历期对齐
经营现金流FAMIRMTI
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | $14.6M | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | $-14.9M | $-2.4M |
自由现金流FAMIRMTI
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | $14.6M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
自由现金流率FAMIRMTI
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | 90.1% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
资本支出强度FAMIRMTI
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | 0.0% | 0.6% |
现金转化率FAMIRMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | -23.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FAMI
暂无分部数据
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
